Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
20 : 19 Taglialatela G, Navarra D, Cruciani R, Ramacci MT, Alema GS, Angelucci L
Dosage adjustment is not necessary with renal or hepatic impairment
Afamelanotide was carried down the full pharmaceutical pathway: a defined molecule, a slow-release implant formulation, controlled clinical trials, and eventually orphan-drug approval for a rare disease
: Freepik.
Quantitative analysis of platelet surface HLA by W6/32 anti-HLA monoclonal antibody
US$ 24.13
US$ 28.92
US$ 23.68
US$ 20.31
US$ 20.45
US$ 24.20
US$ 26.79
US$ 20.73
US$ 20.98
US$ 22.48
US$ 27.71
US$ 28.18
